Literature DB >> 7082675

Mode of action of heparin lyase on heparin.

R J Linhardt, G L Fitzgerald, C L Cooney, R Langer.   

Abstract

Heparinase (heparin lyase, EC 4.2.2.7) prepared from Flavobacterium heparinum was used to digest heparin. The products of digestion were examined with a viscosometric assay at various stages of the reaction to measure their average molecular weight. By comparison with computer simulations of various models, heparinase was shown to act in a random endolytic mode. The relative abundance of intermediates in heparin degradation catalyzed by heparinase immobilized on Sepharose 4B was measured by high pressure liquid chromatography (HPLC) at various time points. The results obtained using HPLC were consistent with a random endolytic mechanism. The heparin digestion products were separated and identified using gel permeation chromatography. The final distributions of heparin degradation products for free and immobilized heparinase were identical. Contaminating sulfatases and glycuronidases which could have subsequently acted on heparin degradation products were not found in significant amounts in the heparinase preparation studied.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082675     DOI: 10.1016/0167-4838(82)90503-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages.

Authors:  Zhongping Xiao; Wenjing Zhao; Bo Yang; Zhenqing Zhang; Huashi Guan; Robert J Linhardt
Journal:  Glycobiology       Date:  2010-08-20       Impact factor: 4.313

2.  Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.

Authors:  S Ernst; A J Rhomberg; K Biemann; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

3.  A computational approach for deciphering the organization of glycosaminoglycans.

Authors:  Jean L Spencer; Joel A Bernanke; Jo Ann Buczek-Thomas; Matthew A Nugent
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

4.  Large scale preparation and characterization of mucopolysaccharase contamination free heparinase.

Authors:  V C Yang; H Bernstein; C L Cooney; R Langer
Journal:  Appl Biochem Biotechnol       Date:  1987 Sep-Dec       Impact factor: 2.926

Review 5.  Polysaccharide lyases.

Authors:  R J Linhardt; P M Galliher; C L Cooney
Journal:  Appl Biochem Biotechnol       Date:  1986-04       Impact factor: 2.926

6.  An immobilized microbial heparinase for blood deheparinization.

Authors:  R J Linhardt; C L Cooney; D Tapper; C A Zannetos; A K Larsen; R Langer
Journal:  Appl Biochem Biotechnol       Date:  1984-02       Impact factor: 2.926

7.  Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin.

Authors:  Zhongping Xiao; Britney R Tappen; Mellisa Ly; Wenjing Zhao; Lauren P Canova; Huashi Guan; Robert J Linhardt
Journal:  J Med Chem       Date:  2010-12-17       Impact factor: 7.446

8.  Fluorescent-tagged heparan sulfate precursor oligosaccharides to probe the enzymatic action of heparitinase I.

Authors:  Ponnusamy Babu; Balagurunathan Kuberan
Journal:  Anal Biochem       Date:  2009-09-02       Impact factor: 3.365

9.  Fractionation of heparin-derived oligosaccharides by gradient polyacrylamide-gel electrophoresis.

Authors:  K G Rice; M K Rottink; R J Linhardt
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

10.  Structure of heparin-derived tetrasaccharides.

Authors:  Z M Merchant; Y S Kim; K G Rice; R J Linhardt
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.